🔗 Share this article

An underground market for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and vendors on communication apps, according to new investigations.

Investigational Drug Acquiring Popularity Via Social Media

Retatrutide, which remains in research studies, is being promoted by online personalities for its supposed fat-burning effects. Followers are encouraged to message these accounts directly for source information, while also receiving promotional offers.

Active Trade on Messaging Platforms

Additionally, a robust trade exists on Telegram, where groups with numerous of members share comparison photos, injection guides and claims of next-day UK delivery. Sellers promote the substance there before redirecting customers to other platforms for transactions.

Learning About Retatrutide

Retatrutide is an experimental injectable developed by US drugmaker Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could assist patients reduce up to 25% of their total weight. Referred to as the “triple G”, the substance is being hailed online as the next Ozempic.

Medical Professionals Express Concerns

However, physicians and pharmacists have cautions that the sale of what remains an unapproved medication in the United Kingdom is a cause for concern and could lead to users administering substances of unknown origin.

Several professionals stated the popularity for retatrutide could be connected to the rising cost of licensed weight loss treatments such as Mounjaro.

Legal Position and Enforcement

Marketing the unapproved drug on social media or messaging apps is illegal in the UK, as it is an unlicensed drug that must not be marketed or supplied for human use under the Human Medicines Regulations 2012.

Some content creators try to circumvent the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and supply can still breach medicines, advertising, and customer regulations, risking fines, legal action or imprisonment.

Service Response and Content Removal

According to TikTok, the service has removed violative content and prohibited associated keywords and search suggestions. The company stated it was committed to keeping the service safe and allocating resources in enhancing enforcement strategies.

Online Marketplace Operations

Investigations also discovered communities with up to 9,000 participants marketing the experimental drug using Telegram's integrated discovery tool, which functions like a public directory. Entering “retatrutide” immediately displays channels with thousands of members, populated with images of slimming results, positive reviews and step-by-step instructions for preparing or injecting at home.

After minutes of entering one community, a vendor posted WhatsApp details, where most transactions occur. The vendor sent an instruction manual and guaranteed shipping within 48 hours. When asked whether the substance was genuine, one seller responded: “You can’t be sure.” Another provided a photo of a alleged testing documentation. None asked about body mass, health issues or past usage.

Item Information and Pricing

Within these communities, messages show black plastic packages with Royal Mail stickers, stating to include new batches. One communication stated: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, mixed at residence with purified liquid, or ready-to-use pens usually priced at £160 for 20mg. When questioned how long a injector should be used, vendors give conflicting answers ranging from a several days to “depends on your body”.

Service Moderation and Security Measures

A spokesperson for Telegram said it actively moderated dangerous content on its platform including content that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“Individuals are administering materials they cannot confirm. Even if the science behind retatrutide is valid, these digital versions may not contain what they claim,” stated a pharmacy expert, the head of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor connected the increase in demand to recent cost increases for approved slimming drugs such as Mounjaro. “With prices increasing, individuals are using social media. But counterfeit treatments are extremely dangerous. You can’t be certain what’s contained or whether the environment they were made in was clean,” she explained.

Her team has already encountered patients harmed by self-injection from unverified suppliers. “We recognize the disappointment, but buying from Telegram or communication platforms is gambling with your well-being,” stated the doctor. “These materials could be contaminated or improperly measured.”

Producer Statement

A representative from Eli Lilly said retatrutide was in phase 3 clinical trials and had not been evaluated or approved by any regulatory agency globally. “Therefore at this time no one can sell [it] for human use,” they said, noting that any product “misleadingly claiming itself as a Lilly investigational substance not yet authorized … may subject patients to potentially serious medical dangers”.